Australia

Showing 11-20 of 27 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Monitoring CD4+ T-cell responses in T1D, MS and SLE	St. Vincent's Institute of Medical Research	Stuart Mannering	Cures	01-September-2025 to 31-August-2026	$149,998.36
Harnessing T cell exhaustion for type 1 diabetes prevention	St. Vincent's Institute of Medical Research	Thomas Kay	Cures	01-November-2023 to 31-October-2026	$2,250,000.00
Experiences of children with early-stage T1D and their families in three Australian monitoring cohorts: what matters most for engagement in a national program?	The University of Adelaide	Jennifer Couper	Cures	01-February-2025 to 31-January-2027	$179,817.84
Investigating the utility of urine C-peptide in early-stage T1D	The University of Adelaide	Jennifer Couper	Cures	01-September-2024 to 31-July-2026	$93,760.34
Expanded data mining of accumulated functional genomics data for identifying mechanistic biomarkers informative of T1D risk and prevention	The University of Adelaide	Megan Penno	Cures	01-June-2024 to 31-May-2027	$444,306.96
Using Multi-omics to turn islet autoimmunity driver genes into therapies	The University of Adelaide	Simon Barry	Cures	01-August-2024 to 31-July-2027	$446,624.00
Finding T1D driver genes: Targets for future therapies	The University of Adelaide	Ying Wong	Cures	01-March-2024 to 28-February-2027	$267,920.00
Improving Glucose Levels while Preventing Ketoacidosis in People with Type 1 Diabetes Receiving SGLT1/2 inhibitor Therapy Using a Novel Continuous Ketone Sensor (PARTNER)	The University of Melbourne	David O'Neal	Improving Lives	01-November-2024 to 31-October-2026	$221,126.00
Understanding RAGE Expression and Function in Human T and Dendritic Cells to Refine the Use of RAGE Targeting Therapeutics for Type 1 Diabetes Prevention.	The University of Queensland	Josephine Forbes	Cures	01-April-2024 to 31-March-2026	$200,000.00
FAME-1 Eye Trial Completion	The University of Sydney	Alicia Jenkins	Improving Lives	01-July-2025 to 30-June-2028	$545,454.35